Nanotheranostic Carbon Dots as an Emerging Platform for Cancer Therapy
1
Department of Pharmaceutical Sciences, North South University, Dhaka 1229, Bangladesh
2
Department of Carbon Convergence Engineering, Wonkwang University, Iksan, Jeonbuk 54538, Korea
*
Author to whom correspondence should be addressed.
Academic Editor: Seok Ki Choi
J. Nanotheranostics 2020, 1(1), 58-77; https://doi.org/10.3390/jnt1010006
Received: 30 September 2020
/
Revised: 10 November 2020
/
Accepted: 13 November 2020
/
Published: 23 November 2020
Cancer remains one of the most deadly diseases globally, but carbon-based nanomaterials have the potential to revolutionize cancer diagnosis and therapy. Advances in nanotechnology and a better understanding of tumor microenvironments have contributed to novel nanotargeting routes that may bring new hope to cancer patients. Several low-dimensional carbon-based nanomaterials have shown promising preclinical results; as such, low-dimensional carbon dots (CDs) and their derivatives are considered up-and-coming candidates for cancer treatment. The unique properties of carbon-based nanomaterials are high surface area to volume ratio, chemical inertness, biocompatibility, and low cytotoxicity. It makes them well suited for delivering chemotherapeutics in cancer treatment and diagnosis. Recent studies have shown that the CDs are potential applicants in biomedical sciences, both as nanocarriers and nanotransducers. This review covers the most commonly used CD nanoparticles in nanomedicines intended for the early diagnosis and therapy of cancer.
View Full-Text
Keywords:
carbon nanoparticles; CDs; bioimaging; drug delivery system; theranostic
▼
Show Figures
Graphical abstract
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Adrita, S.H.; Tasnim, K.N.; Ryu, J.H.; Sharker, S.M. Nanotheranostic Carbon Dots as an Emerging Platform for Cancer Therapy. J. Nanotheranostics 2020, 1, 58-77. https://doi.org/10.3390/jnt1010006
AMA Style
Adrita SH, Tasnim KN, Ryu JH, Sharker SM. Nanotheranostic Carbon Dots as an Emerging Platform for Cancer Therapy. Journal of Nanotheranostics. 2020; 1(1):58-77. https://doi.org/10.3390/jnt1010006
Chicago/Turabian StyleAdrita, Sumiya H., Khandaker N. Tasnim, Ji H. Ryu, and Shazid M. Sharker. 2020. "Nanotheranostic Carbon Dots as an Emerging Platform for Cancer Therapy" Journal of Nanotheranostics 1, no. 1: 58-77. https://doi.org/10.3390/jnt1010006
Find Other Styles
